Applied Therapeutics (APLT) News Today $0.37 0.00 (-0.70%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Applied Therapeutics reports FY24 EPS (76c), consensus ($1.33)April 15 at 1:48 AM | markets.businessinsider.comApplied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial ResultsApril 15 at 1:48 AM | markets.businessinsider.comApplied Therapeutics files Form 12b-25 with SECApril 1, 2025 | markets.businessinsider.comApplied Therapeutics Delays Yearly Report FilingMarch 31, 2025 | tipranks.comApplied Therapeutics Files Form 12b-25 with the Securities and Exchange CommissionMarch 31, 2025 | globenewswire.comApplied Therapeutics appoints Baumgartner as Chief Regulatory OfficerMarch 20, 2025 | markets.businessinsider.comApplied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory OfficerMarch 19, 2025 | globenewswire.comApplied Therapeutics, Inc. (NASDAQ:APLT) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six research firms that are presently covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendatioMarch 13, 2025 | marketbeat.com3 Penny Stocks With At Least $50M Market CapMarch 12, 2025 | uk.finance.yahoo.comApplied Therapeutics (APLT) Expected to Announce Quarterly Earnings on WednesdayApplied Therapeutics (NASDAQ:APLT) will be releasing earnings before the market opens on Wednesday, March 5, Financial Modeling Prep reports.March 3, 2025 | marketbeat.comApplied Therapeutics (APLT) to Release Earnings on WednesdayApplied Therapeutics (NASDAQ:APLT) will be releasing earnings before the market opens on Wednesday, March 5, Financial Modeling Prep reports.February 26, 2025 | marketbeat.comAPLT DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLTFebruary 18, 2025 | investing.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied TherapeuticsFebruary 18, 2025 | tmcnet.comClass Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & KorsinskyFebruary 18, 2025 | prnewswire.comAPLT DEADLINE TOMORROW: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLTFebruary 17, 2025 | investing.comAPLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLTFebruary 17, 2025 | globenewswire.comINVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. ...February 17, 2025 | gurufocus.comINVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLTFebruary 17, 2025 | prnewswire.comAPLT Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action LawsuitFebruary 16, 2025 | prnewswire.comAPLT IMPORTANT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action -February 16, 2025 | investing.comAPLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. ...February 16, 2025 | gurufocus.comAPLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud LawsuitFebruary 16, 2025 | prnewswire.comAPLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT)February 16, 2025 | globenewswire.comApplied Therapeutics, Inc. (NASDAQ:APLT) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Applied Therapeutics, Inc. (NASDAQ:APLT - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven ratings firms that are currently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation andFebruary 16, 2025 | marketbeat.comAPLT COURT DEADLINE: Applied Therapeutics Investors are Alerted to Contact BFA Law before February 18 Class Action DeadlineFebruary 15, 2025 | markets.businessinsider.comAPLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. ...February 15, 2025 | gurufocus.comAPLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their RightsFebruary 15, 2025 | businesswire.comINVESTOR DEADLINE TUESDAY: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLTFebruary 14, 2025 | investing.comKaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)February 14, 2025 | theglobeandmail.comAPLT DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLTFebruary 14, 2025 | globenewswire.comDeadline Soon: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud LawsuitFebruary 14, 2025 | businesswire.comAPLT Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action LawsuitFebruary 14, 2025 | globenewswire.comApplied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLTFebruary 14, 2025 | prnewswire.comApplied Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 18, 2025 Deadline to file Lead Plaintiff Motion.February 13, 2025 | globenewswire.comAPLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineFebruary 13, 2025 | globenewswire.comApplied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitFebruary 13, 2025 | prnewswire.comINVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLTFebruary 13, 2025 | globenewswire.comShareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLTFebruary 13, 2025 | prnewswire.comAPLT stock touches 52-week low at $0.54 amid market challengesFebruary 12, 2025 | msn.comAPLT LAWSUIT ALERT: The Gross Law Firm Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineFebruary 12, 2025 | globenewswire.comApplied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitFebruary 12, 2025 | prnewswire.comAPLT CLASS ACTION REPORT: Applied Therapeutics is being Sued for Securities Fraud; Investors are Urged to Contact BFA Law by February 18 Deadline (NASDAQ:APLT)February 12, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLTFebruary 11, 2025 | prnewswire.comAPLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud LawsuitFebruary 11, 2025 | prnewswire.comAPLT CLASS ACTION UPDATE: Applied Therapeutics Investors are Reminded to Contact BFA Law before Imminent February 18 DeadlineFebruary 11, 2025 | markets.businessinsider.comAPLT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLTFebruary 11, 2025 | globenewswire.comClass Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & KorsinskyFebruary 11, 2025 | prnewswire.comAPLT Lawsuit Alert! Class Action Against Applied Therapeutics, Inc.February 11, 2025 | tipranks.comApplied Therapeutics faces Nasdaq delisting over share priceFebruary 11, 2025 | msn.comAPLT INVESTOR ALERT: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Stockholder Class Action LawsuitFebruary 11, 2025 | markets.businessinsider.com Remove Ads Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address APLT Media Mentions By Week APLT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APLT News Sentiment▼1.470.80▲Average Medical News Sentiment APLT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APLT Articles This Week▼28▲APLT Articles Average Week Remove Ads Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Eledon Pharmaceuticals News CARGO Therapeutics News AC Immune News Tevogen Bio News biote News Genfit News Voyager Therapeutics News Amarin News Humacyte News Rezolute News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APLT) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
